Knowledge on rare diseases and orphan drugs
COVID-19 & Rare diseases
Rare Diseases Resources for Refugees/Displaced Persons
Search for a rare disease
De novo thrombotic microangiopathy after kidney transplantation
A rare renal disease characterized by thrombotic microangiopathy developing de novo in kidney transplant recipients with no evidence of occurrence of the disease prior to transplantation. Precipitating factors include antibody-mediated rejection, immunosuppressive medication, viral infections, and genetic abnormalities in the complement cascade, among others. The condition most commonly occurs within the first 3-6 months post-transplantation. Clinical presentation is highly variable and ranges from a limited form confined to the kidney with relatively good prognosis to a systemic variant consisting of the classic triad of thrombocytopenia, microangiopathic hemolytic anemia, and acute kidney injury.
ORPHA:244275
: produced/endorsed by ERN(s)
: produced/endorsed by FSMR(s)
Guidelines
Further information on this disease
Patient-centred resources for this disease
Research activities on this disease
- Research project(s) (32)
- Clinical trial(s) (1)
- Biobank(s) (4)
- Registry(ies) (24)
- Network of experts (3)
Newborn screening